| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.83e-05 | 18 | 74 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 8.02e-05 | 119 | 74 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.50e-04 | 28 | 74 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | alpha-ketoglutarate transmembrane transporter activity | 2.01e-04 | 6 | 74 | 2 | GO:0015139 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.33e-04 | 81 | 74 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | symporter activity | 2.38e-04 | 150 | 74 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.47e-04 | 37 | 74 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | sphingomyelin phosphodiesterase activity | 3.74e-04 | 8 | 74 | 2 | GO:0004767 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 3.79e-04 | 477 | 74 | 8 | GO:0022804 | |
| GeneOntologyMolecularFunction | protein-glutamine gamma-glutamyltransferase activity | 4.80e-04 | 9 | 74 | 2 | GO:0003810 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 8.03e-04 | 296 | 74 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 8.73e-04 | 12 | 74 | 2 | GO:0005436 | |
| GeneOntologyMolecularFunction | palmitoyl hydrolase activity | 1.20e-03 | 14 | 74 | 2 | GO:0098599 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.24e-03 | 70 | 74 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 2.72e-03 | 21 | 74 | 2 | GO:0034987 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 2.90e-03 | 807 | 74 | 9 | GO:0016788 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 3.55e-03 | 24 | 74 | 2 | GO:0005315 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.75e-03 | 171 | 74 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.75e-03 | 171 | 74 | 4 | GO:0015081 | |
| GeneOntologyCellularComponent | dimeric IgA immunoglobulin complex | 3.80e-05 | 3 | 75 | 2 | GO:0071750 | |
| GeneOntologyCellularComponent | secretory dimeric IgA immunoglobulin complex | 3.80e-05 | 3 | 75 | 2 | GO:0071752 | |
| GeneOntologyCellularComponent | monomeric IgA immunoglobulin complex | 4.50e-04 | 9 | 75 | 2 | GO:0071748 | |
| GeneOntologyCellularComponent | polymeric IgA immunoglobulin complex | 5.61e-04 | 10 | 75 | 2 | GO:0071749 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex, circulating | 5.61e-04 | 10 | 75 | 2 | GO:0071746 | |
| GeneOntologyCellularComponent | secretory IgA immunoglobulin complex | 5.61e-04 | 10 | 75 | 2 | GO:0071751 | |
| GeneOntologyCellularComponent | dynein complex | 9.65e-04 | 54 | 75 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex | 1.29e-03 | 15 | 75 | 2 | GO:0071745 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.66e-03 | 238 | 75 | 5 | GO:0097729 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 1.67e-03 | 17 | 75 | 2 | GO:0042571 | |
| HumanPheno | Decreased fertility | FSIP2 PATL2 CYP11A1 NPAP1 DNAH2 SLC34A2 MEI1 ZP3 DNAH9 HYDIN DNAH11 CFAP65 | 9.27e-08 | 380 | 26 | 12 | HP:0000144 |
| HumanPheno | Infertility | 1.50e-06 | 314 | 26 | 10 | HP:0000789 | |
| HumanPheno | Female infertility | 2.97e-06 | 84 | 26 | 6 | HP:0008222 | |
| HumanPheno | Decreased fertility in females | 1.04e-05 | 104 | 26 | 6 | HP:0000868 | |
| HumanPheno | Abnormal sperm motility | 1.85e-05 | 115 | 26 | 6 | HP:0012206 | |
| HumanPheno | Abnormal sperm physiology | 1.85e-05 | 115 | 26 | 6 | HP:0034809 | |
| HumanPheno | Neonatal respiratory distress | 9.66e-05 | 154 | 26 | 6 | HP:0002643 | |
| HumanPheno | Premature birth | 2.08e-04 | 177 | 26 | 6 | HP:0001622 | |
| Domain | DHC_N1 | 3.16e-06 | 8 | 73 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 3.16e-06 | 8 | 73 | 3 | IPR013594 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.02e-05 | 14 | 73 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.02e-05 | 14 | 73 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.02e-05 | 14 | 73 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.02e-05 | 14 | 73 | 3 | PF08393 | |
| Domain | MT | 2.02e-05 | 14 | 73 | 3 | PF12777 | |
| Domain | AAA_8 | 2.02e-05 | 14 | 73 | 3 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.02e-05 | 14 | 73 | 3 | IPR011704 | |
| Domain | AAA_5 | 2.02e-05 | 14 | 73 | 3 | PF07728 | |
| Domain | DHC_fam | 2.52e-05 | 15 | 73 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.52e-05 | 15 | 73 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 2.52e-05 | 15 | 73 | 3 | PF03028 | |
| Domain | DSL | 9.00e-05 | 4 | 73 | 2 | PF01414 | |
| Domain | DSL | 9.00e-05 | 4 | 73 | 2 | SM00051 | |
| Domain | DSL | 1.50e-04 | 5 | 73 | 2 | IPR001774 | |
| Domain | DSL | 1.50e-04 | 5 | 73 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 1.50e-04 | 5 | 73 | 2 | IPR011651 | |
| Domain | MNNL | 1.50e-04 | 5 | 73 | 2 | PF07657 | |
| Domain | Transglut_N | 5.33e-04 | 9 | 73 | 2 | PF00868 | |
| Domain | TRANSGLUTAMINASES | 5.33e-04 | 9 | 73 | 2 | PS00547 | |
| Domain | Transglutaminase_N | 5.33e-04 | 9 | 73 | 2 | IPR001102 | |
| Domain | Transglut_C | 5.33e-04 | 9 | 73 | 2 | PF00927 | |
| Domain | - | 5.33e-04 | 9 | 73 | 2 | 3.90.260.10 | |
| Domain | Gln_gamma-glutamylTfrase_euk | 5.33e-04 | 9 | 73 | 2 | IPR023608 | |
| Domain | Transglutaminase_AS | 5.33e-04 | 9 | 73 | 2 | IPR013808 | |
| Domain | PapD-like | 5.33e-04 | 9 | 73 | 2 | IPR008962 | |
| Domain | Transglutaminase_C | 6.64e-04 | 10 | 73 | 2 | IPR008958 | |
| Domain | TGc | 8.10e-04 | 11 | 73 | 2 | SM00460 | |
| Domain | Transglut_core | 8.10e-04 | 11 | 73 | 2 | PF01841 | |
| Domain | Transglutaminase-like | 8.10e-04 | 11 | 73 | 2 | IPR002931 | |
| Domain | C1-set | 1.23e-03 | 54 | 73 | 3 | PF07654 | |
| Domain | SEA | 1.33e-03 | 14 | 73 | 2 | SM00200 | |
| Domain | IGc1 | 1.37e-03 | 56 | 73 | 3 | SM00407 | |
| Domain | Ig_C1-set | 1.52e-03 | 58 | 73 | 3 | IPR003597 | |
| Domain | - | 1.53e-03 | 15 | 73 | 2 | 3.30.70.960 | |
| Domain | AAA+_ATPase | 2.44e-03 | 144 | 73 | 4 | IPR003593 | |
| Domain | AAA | 2.44e-03 | 144 | 73 | 4 | SM00382 | |
| Domain | SEA | 3.31e-03 | 22 | 73 | 2 | PF01390 | |
| Domain | SEA | 3.61e-03 | 23 | 73 | 2 | PS50024 | |
| Domain | SEA_dom | 3.61e-03 | 23 | 73 | 2 | IPR000082 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.54e-04 | 27 | 55 | 3 | M47755 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 3.10e-04 | 7 | 55 | 2 | M27199 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 3.10e-04 | 7 | 55 | 2 | M47805 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HYDROLYSIS_OF_SPHINGOMYELIN | 4.12e-04 | 8 | 55 | 2 | M47611 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_CATABOLISM | 4.65e-04 | 39 | 55 | 3 | M48042 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 5.29e-04 | 9 | 55 | 2 | M47866 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 6.21e-04 | 43 | 55 | 3 | M47669 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM | 6.59e-04 | 10 | 55 | 2 | M27573 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 7.10e-04 | 45 | 55 | 3 | M47670 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 36140829 | ||
| Pubmed | 3.63e-07 | 7 | 77 | 3 | 31178125 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16517606 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 2241915 | ||
| Pubmed | Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle. | 4.84e-06 | 2 | 77 | 2 | 25180167 | |
| Pubmed | Suppression of Th2 cell development by Notch ligands Delta1 and Delta4. | 4.84e-06 | 2 | 77 | 2 | 18209061 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16393955 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20548034 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11035934 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19342447 | ||
| Pubmed | DLL1- and DLL4-Mediated Notch Signaling Is Essential for Adult Pancreatic Islet Homeostasis. | 4.84e-06 | 2 | 77 | 2 | 32029480 | |
| Pubmed | Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. | 4.84e-06 | 2 | 77 | 2 | 15146182 | |
| Pubmed | Induction of T-cell development by Delta-like 4-expressing fibroblasts. | 4.84e-06 | 2 | 77 | 2 | 23988616 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15728481 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 31934853 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19250608 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25041739 | ||
| Pubmed | 8.31e-06 | 18 | 77 | 3 | 15689374 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 12684674 | ||
| Pubmed | Ceramide triggers budding of exosome vesicles into multivesicular endosomes. | 1.45e-05 | 3 | 77 | 2 | 18309083 | |
| Pubmed | Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions. | 1.45e-05 | 3 | 77 | 2 | 21372153 | |
| Pubmed | Lack of Delta like 1 and 4 expressions in nude thymus anlages. | 1.45e-05 | 3 | 77 | 2 | 16095582 | |
| Pubmed | DLL4 and Jagged1 are angiogenic targets of orphan nuclear receptor TR3/Nur77. | 1.45e-05 | 3 | 77 | 2 | 30930165 | |
| Pubmed | Intrinsic selectivity of Notch 1 for Delta-like 4 over Delta-like 1. | 1.45e-05 | 3 | 77 | 2 | 23839946 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 18824585 | ||
| Pubmed | Notch ligands transduce different magnitudes of signaling critical for determination of T-cell fate. | 2.89e-05 | 4 | 77 | 2 | 20602435 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 24145934 | ||
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 2.89e-05 | 4 | 77 | 2 | 32820046 | |
| Pubmed | No evidence for a functional role of bi-directional Notch signaling during angiogenesis. | 2.89e-05 | 4 | 77 | 2 | 23300864 | |
| Pubmed | Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands. | 2.89e-05 | 4 | 77 | 2 | 28319044 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 19698806 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 27965096 | ||
| Pubmed | Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy. | 2.89e-05 | 4 | 77 | 2 | 23398317 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 23162128 | ||
| Pubmed | 3.66e-05 | 29 | 77 | 3 | 25535917 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 3.70e-05 | 168 | 77 | 5 | 30631154 | |
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 4.06e-05 | 30 | 77 | 3 | 24552588 | |
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 4.82e-05 | 5 | 77 | 2 | 21726900 | |
| Pubmed | Neuralized-2: expression in human and rodents and interaction with Delta-like ligands. | 4.82e-05 | 5 | 77 | 2 | 19723503 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 19110448 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 6421489 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 26909801 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 23250751 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 30181175 | ||
| Pubmed | Redd1 is a novel marker of testis development but is not required for normal male reproduction. | 7.22e-05 | 6 | 77 | 2 | 22797524 | |
| Pubmed | Cutting edge: thymic crosstalk regulates delta-like 4 expression on cortical epithelial cells. | 7.22e-05 | 6 | 77 | 2 | 19050235 | |
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 33347437 | ||
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 19217325 | ||
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 35091558 | ||
| Pubmed | Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo. | 1.01e-04 | 7 | 77 | 2 | 26114479 | |
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 29536159 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 24025447 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 32060138 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 11390390 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 9256245 | ||
| Pubmed | Regulation of monocyte cell fate by blood vessels mediated by Notch signalling. | 1.01e-04 | 7 | 77 | 2 | 27576369 | |
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 24505141 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 30289388 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 14726490 | ||
| Pubmed | Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. | 1.01e-04 | 7 | 77 | 2 | 21238454 | |
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 7906657 | ||
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 7688299 | ||
| Pubmed | Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. | 1.34e-04 | 8 | 77 | 2 | 24647000 | |
| Pubmed | 1.72e-04 | 9 | 77 | 2 | 16245338 | ||
| Pubmed | 1.72e-04 | 9 | 77 | 2 | 15509740 | ||
| Pubmed | Notch1 expression and ligand interactions in progenitor cells of the mouse olfactory epithelium. | 1.72e-04 | 9 | 77 | 2 | 17605079 | |
| Pubmed | Dll4 and Notch signalling couples sprouting angiogenesis and artery formation. | 1.72e-04 | 9 | 77 | 2 | 28714968 | |
| Pubmed | A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization. | 1.72e-04 | 9 | 77 | 2 | 21788370 | |
| Pubmed | Expression of Phosphate Transporters during Dental Mineralization. | 1.72e-04 | 9 | 77 | 2 | 28892649 | |
| Pubmed | Monitoring Notch1 activity in development: evidence for a feedback regulatory loop. | 1.72e-04 | 9 | 77 | 2 | 17685488 | |
| Pubmed | Pax2 and Pax8 cooperate in mouse inner ear morphogenesis and innervation. | 1.72e-04 | 9 | 77 | 2 | 20727173 | |
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 1.72e-04 | 9 | 77 | 2 | 10837027 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.15e-04 | 10 | 77 | 2 | 23665443 | |
| Pubmed | 2.15e-04 | 10 | 77 | 2 | 24015274 | ||
| Pubmed | 3.15e-04 | 12 | 77 | 2 | 15465494 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 3.71e-04 | 13 | 77 | 2 | 11578869 | |
| Pubmed | Notch signaling is required for the maintenance of enteric neural crest progenitors. | 3.71e-04 | 13 | 77 | 2 | 18832397 | |
| Pubmed | 4.33e-04 | 14 | 77 | 2 | 9373155 | ||
| Pubmed | 4.33e-04 | 14 | 77 | 2 | 14757642 | ||
| Pubmed | 4.99e-04 | 15 | 77 | 2 | 20176268 | ||
| Pubmed | 4.99e-04 | 15 | 77 | 2 | 12971992 | ||
| Pubmed | Rotatin is a novel gene required for axial rotation and left-right specification in mouse embryos. | 5.69e-04 | 16 | 77 | 2 | 11900971 | |
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 5.69e-04 | 16 | 77 | 2 | 12617809 | |
| Pubmed | A conserved YAP/Notch/REST network controls the neuroendocrine cell fate in the lungs. | 5.69e-04 | 16 | 77 | 2 | 35577801 | |
| Pubmed | 5.69e-04 | 16 | 77 | 2 | 17273555 | ||
| Pubmed | 5.69e-04 | 16 | 77 | 2 | 22464328 | ||
| Pubmed | Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. | 5.69e-04 | 16 | 77 | 2 | 19679677 | |
| Pubmed | 6.44e-04 | 17 | 77 | 2 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 6.44e-04 | 17 | 77 | 2 | 15821257 | |
| Pubmed | 6.44e-04 | 17 | 77 | 2 | 39315665 | ||
| Pubmed | Cbx4 regulates the proliferation of thymic epithelial cells and thymus function. | 6.44e-04 | 17 | 77 | 2 | 23362346 | |
| Pubmed | 7.23e-04 | 18 | 77 | 2 | 18093989 | ||
| Pubmed | 8.07e-04 | 19 | 77 | 2 | 18505817 | ||
| Pubmed | 8.07e-04 | 19 | 77 | 2 | 7628695 | ||
| Pubmed | 8.07e-04 | 19 | 77 | 2 | 20335360 | ||
| Pubmed | 8.07e-04 | 19 | 77 | 2 | 16518823 | ||
| Pubmed | 8.07e-04 | 19 | 77 | 2 | 25691540 | ||
| Pubmed | A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. | 8.96e-04 | 20 | 77 | 2 | 12588999 | |
| Pubmed | Mesenchymal cells are required for functional development of thymic epithelial cells. | 9.89e-04 | 21 | 77 | 2 | 17625108 | |
| Pubmed | Jagged and Delta-like ligands control distinct events during airway progenitor cell differentiation. | 9.89e-04 | 21 | 77 | 2 | 31631837 | |
| Cytoband | 15q15.2 | 3.28e-04 | 16 | 77 | 2 | 15q15.2 | |
| GeneFamily | Dyneins, axonemal | 1.57e-05 | 17 | 53 | 3 | 536 | |
| GeneFamily | Transglutaminases | 3.00e-04 | 9 | 53 | 2 | 773 | |
| GeneFamily | Solute carriers | 1.01e-03 | 395 | 53 | 6 | 752 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-09 | 191 | 77 | 8 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-09 | 191 | 77 | 8 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-09 | 191 | 77 | 8 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 1.49e-09 | 191 | 77 | 8 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-09 | 191 | 77 | 8 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-09 | 191 | 77 | 8 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-09 | 191 | 77 | 8 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-09 | 191 | 77 | 8 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 1.49e-09 | 191 | 77 | 8 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-09 | 191 | 77 | 8 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 1.49e-09 | 191 | 77 | 8 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 1.49e-09 | 191 | 77 | 8 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-08 | 173 | 77 | 7 | 62abaaaf48cabd1423f17fb27c33b75ea88867f4 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-08 | 173 | 77 | 7 | 09cd878c33534bd476d6a4880f5582076189da8c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.35e-08 | 185 | 77 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-08 | 191 | 77 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-08 | 191 | 77 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-08 | 191 | 77 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | ASK454|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.32e-08 | 192 | 77 | 7 | 6b047b445a0df0ecdd6d7baf388a0d966a93b3a2 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.63e-08 | 194 | 77 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 4.63e-08 | 194 | 77 | 7 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 5.15e-08 | 197 | 77 | 7 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-08 | 199 | 77 | 7 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.51e-08 | 199 | 77 | 7 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 5.51e-08 | 199 | 77 | 7 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-08 | 199 | 77 | 7 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.51e-08 | 199 | 77 | 7 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 5.51e-08 | 199 | 77 | 7 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 5.51e-08 | 199 | 77 | 7 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.51e-08 | 199 | 77 | 7 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.89e-07 | 169 | 77 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-07 | 173 | 77 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-07 | 173 | 77 | 6 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-07 | 173 | 77 | 6 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-07 | 173 | 77 | 6 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.54e-07 | 182 | 77 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 7.54e-07 | 182 | 77 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.03e-07 | 184 | 77 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-07 | 185 | 77 | 6 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.29e-07 | 185 | 77 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.29e-07 | 185 | 77 | 6 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.29e-07 | 185 | 77 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.56e-07 | 186 | 77 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.56e-07 | 186 | 77 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 9.11e-07 | 188 | 77 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 9.11e-07 | 188 | 77 | 6 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.11e-07 | 188 | 77 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.11e-07 | 188 | 77 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.39e-07 | 189 | 77 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.39e-07 | 189 | 77 | 6 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 9.39e-07 | 189 | 77 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 9.39e-07 | 189 | 77 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.99e-07 | 191 | 77 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.99e-07 | 191 | 77 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 9.99e-07 | 191 | 77 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.99e-07 | 191 | 77 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.99e-07 | 191 | 77 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.99e-07 | 191 | 77 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | 1.03e-06 | 192 | 77 | 6 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 | |
| ToppCell | Ciliated-cil-3|World / Class top | 1.03e-06 | 192 | 77 | 6 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 1.03e-06 | 192 | 77 | 6 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.03e-06 | 192 | 77 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.03e-06 | 192 | 77 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.06e-06 | 193 | 77 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 1.06e-06 | 193 | 77 | 6 | aa3acc7571405169efb656d214f3a8cbf988362e | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.09e-06 | 194 | 77 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.09e-06 | 194 | 77 | 6 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-06 | 194 | 77 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.13e-06 | 195 | 77 | 6 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.13e-06 | 195 | 77 | 6 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.13e-06 | 195 | 77 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.13e-06 | 195 | 77 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.13e-06 | 195 | 77 | 6 | e7f069f557a59ee7b502ff82ad4c9f47fa619ba8 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 196 | 77 | 6 | a37ba02446eef5d1fab703204583f6550a8ec3e1 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 1.16e-06 | 196 | 77 | 6 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.16e-06 | 196 | 77 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 196 | 77 | 6 | a156840330630e518bc85633dded6f2c3ead3b30 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 196 | 77 | 6 | 009e83c7251cf300be78b263634d233a8d972a68 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-06 | 196 | 77 | 6 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-06 | 196 | 77 | 6 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-06 | 196 | 77 | 6 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 196 | 77 | 6 | 89ea4d2086e1c769c5a87f1471a6cd4acabcfe33 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.16e-06 | 196 | 77 | 6 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.16e-06 | 196 | 77 | 6 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-06 | 196 | 77 | 6 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 197 | 77 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 197 | 77 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 197 | 77 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 197 | 77 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 197 | 77 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-06 | 197 | 77 | 6 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.23e-06 | 198 | 77 | 6 | 16c54b884500066ade05a406915f9569ca8abdfc | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.23e-06 | 198 | 77 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-06 | 199 | 77 | 6 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-06 | 199 | 77 | 6 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-06 | 199 | 77 | 6 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-06 | 199 | 77 | 6 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 199 | 77 | 6 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-06 | 199 | 77 | 6 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 199 | 77 | 6 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| Drug | celecoxib; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.26e-07 | 189 | 76 | 8 | 922_UP | |
| Drug | 2-bromopalmitate | 2.76e-06 | 66 | 76 | 5 | CID000082145 | |
| Drug | D-8 (pharmaceutical) | 2.96e-06 | 9 | 76 | 3 | CID000107261 | |
| Drug | Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.03e-06 | 195 | 76 | 7 | 1545_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 4.17e-06 | 196 | 76 | 7 | 6942_UP | |
| Drug | 17-hydroxypregnenolone | 1.68e-05 | 46 | 76 | 4 | CID000091451 | |
| Drug | calmidazolium chloride; Up 200; 5uM; MCF7; HG-U133A | 1.90e-05 | 165 | 76 | 6 | 486_UP | |
| Drug | mangrove | 2.55e-05 | 468 | 76 | 9 | CID000000965 | |
| Drug | Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A | 2.92e-05 | 178 | 76 | 6 | 2753_UP | |
| Drug | Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A | 3.41e-05 | 183 | 76 | 6 | 3704_UP | |
| Drug | Man5GlcNAc2 | 3.44e-05 | 55 | 76 | 4 | CID003081562 | |
| Drug | furosemide | 3.48e-05 | 272 | 76 | 7 | CID000003440 | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A | 4.72e-05 | 194 | 76 | 6 | 1856_DN | |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; PC3; HT_HG-U133A | 4.72e-05 | 194 | 76 | 6 | 4624_UP | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.86e-05 | 195 | 76 | 6 | 4723_UP | |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 4629_DN | |
| Drug | ipsapirone | 5.18e-05 | 61 | 76 | 4 | CID000056971 | |
| Drug | DOCP | 5.26e-05 | 22 | 76 | 3 | CID000013126 | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; HL60; HG-U133A | 5.59e-05 | 200 | 76 | 6 | 2044_UP | |
| Drug | N-n-propylnorapomorphine | 7.80e-05 | 25 | 76 | 3 | CID000030137 | |
| Disease | Primary Ciliary Dyskinesia | 2.45e-04 | 47 | 76 | 3 | C4551720 | |
| Disease | Inherited oocyte maturation defect | 7.67e-04 | 16 | 76 | 2 | cv:CN238505 | |
| Disease | phosphatidylcholine 40:6 measurement | 8.68e-04 | 17 | 76 | 2 | EFO_0010389 | |
| Disease | ischemia (biomarker_via_orthology) | 9.75e-04 | 18 | 76 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | eye color | 1.64e-03 | 90 | 76 | 3 | EFO_0003949 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.70e-03 | 197 | 76 | 4 | EFO_0005680 | |
| Disease | intelligence, response to cranial radiation therapy | 2.37e-03 | 28 | 76 | 2 | EFO_0004337, EFO_0010950 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ATFTEGSWSPELPFD | 616 | P40145 | |
| FNSPTPPWLGFVSSF | 301 | B3EWF7 | |
| FSISISLPPFFWRQA | 176 | P28222 | |
| LSGFSVFLLPWAPLS | 136 | Q53TN4 | |
| NEDFHPSWSPSSLPF | 496 | Q9H175 | |
| NPLQLPFNFTWPGTF | 101 | Q9NR61 | |
| PFNFTWPGTFSLIIE | 106 | Q9NR61 | |
| PAVVWLSGFFNPQSF | 4371 | Q96DT5 | |
| TEGWHTTSLFPLFPN | 176 | Q99758 | |
| FKFLAWNSPPLTSEF | 436 | O43299 | |
| TQSFWLFRVSPTTFP | 1161 | O60423 | |
| GLDPFSFEFWDSPFN | 106 | Q8NHS0 | |
| NTFFVPTAPKWDSTG | 61 | O75747 | |
| LSPWDGSFGHFSPSQ | 151 | P22736 | |
| SFTFLTPGPNWDFTL | 51 | Q7Z628 | |
| PTWGIPQSTLTFEFS | 2881 | Q8WXI7 | |
| VGDLPTFFTWEFSSP | 271 | Q6ZU64 | |
| TFFTWEFSSPFQMLP | 276 | Q6ZU64 | |
| GPFELWEPNTTFSST | 526 | P98073 | |
| PLFSGDWSSTFFSFL | 5396 | Q5CZC0 | |
| TSFPIDGTFFNSWLA | 521 | Q9NQC1 | |
| AQPRLGTVPTFDWFF | 41 | A8MUP2 | |
| TFSNFTFWREPLPPF | 866 | Q14693 | |
| GFSDWPSLQPVLFAL | 16 | Q8NGU4 | |
| PFAFLGFLFWSPLQS | 76 | Q9NY59 | |
| SFLSPWPPAVTDASF | 551 | Q9NXE4 | |
| PSFNFLYWSLHQTTP | 956 | Q5TIA1 | |
| PVATVQTTWLFSFPF | 141 | Q9H208 | |
| PDDGVITPWQSSFFG | 226 | Q9UMR5 | |
| FWPTFPSTSSPAQHF | 111 | C9JE40 | |
| FWNDFLTGVFPASPL | 46 | Q8TCG5 | |
| DFLSFQGISWEPSPG | 146 | P15812 | |
| FQFTPFHLGITESSW | 4046 | Q4G0P3 | |
| PFWNQLLSFSFPAPT | 31 | Q7RTS9 | |
| WPKIQGLFSSANSPF | 186 | Q9NX09 | |
| PFGFTWPGTFSLIIE | 111 | O00548 | |
| FSDILSGLPFIGFFW | 66 | Q14534 | |
| FFPQEPLSVTWSESG | 31 | P01876 | |
| PTFFFDPENFDPTRW | 426 | P05108 | |
| DFLPYSTEPFQAWTG | 346 | Q9Y2E5 | |
| FFPQEPLSVTWSESG | 31 | P01877 | |
| PSTVWLTGFFNPQSF | 4341 | Q9NYC9 | |
| LFPPWTFQFQSGDLE | 5921 | Q8NDH2 | |
| LISPAWFQTPTFSFG | 21 | Q6ICI0 | |
| GSFLNWFSFFPLLGR | 216 | Q8N4W6 | |
| IFWLSGFTFPTGFLT | 4276 | Q9P225 | |
| NSWGIPLFSLHSFPS | 556 | Q13183 | |
| FTSPQWGLPFLNGTE | 81 | Q4U2R8 | |
| SWDFSPPSFLETSSP | 206 | Q5VV67 | |
| TQFHFTSWPDFGVPF | 401 | P18433 | |
| LGWPTVNFVATFSSP | 156 | Q9P2F6 | |
| NFFWDPSTSRRFSPP | 16 | Q13950 | |
| TSASPPTFFWANASG | 6 | Q8TDU9 | |
| FSSGLFPLSILGWPN | 791 | P26640 | |
| FWGTILFTTCFFTPG | 196 | Q9P1P4 | |
| PTLLSFPSGDWICTF | 916 | Q9UPN9 | |
| SVPFSFDPNTAAGWL | 301 | Q9UPQ4 | |
| FKNPFTLSVGPESSW | 731 | B5MCY1 | |
| VKTLPFSPSQFLNFW | 446 | P10244 | |
| SLPVWAISTGSFTFF | 261 | Q14916 | |
| DFSPTSPFSTGNFWF | 466 | Q5U5Q3 | |
| SPFSTGNFWFGDTLP | 471 | Q5U5Q3 | |
| TSIWKAFFFTPNFNP | 461 | P08842 | |
| PSTTSVFPFGQAAWD | 1046 | Q9NZP6 | |
| TMLPLSPFWSFLFFF | 376 | Q99884 | |
| FWEDGSVPSPSLFST | 216 | Q2HXU8 | |
| PAFSGLTWAPFLFLF | 121 | Q8N326 | |
| SFTYPFALQAPWLTG | 36 | Q9NQ32 | |
| KTINTDFPFPFAWLT | 401 | O95436 | |
| PWPSQSANFPEFSFD | 1406 | A0JNW5 | |
| FSLGWASPFATPDQG | 276 | Q9NYG2 | |
| NDPFFPLSFLVNSWL | 361 | Q9P2C4 | |
| WASAPNFRPTFSLFS | 441 | Q9BXP2 | |
| PVDSSLAFPWTFPFG | 221 | Q8NCP5 | |
| DGSPLSPFWQDTAFI | 551 | O43548 | |
| PWFLTLFASQFSLGF | 1086 | O60343 | |
| GFSSLFQRPPISSWG | 166 | Q86UQ0 | |
| TPSSVFLSWGFLINP | 126 | Q7Z7G0 | |
| TYPLGTFILLFNPWS | 131 | Q96PF1 | |
| SFSKPSNSWFPVEGS | 301 | P21754 | |
| NFFPENPAFSAWGTS | 121 | Q9BYJ9 | |
| SSWLSAAFPGPAFDF | 206 | Q6ZQT7 | |
| QDPGLPFLFWFSVAS | 586 | Q8IYS2 |